These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 8462021

  • 1. Modulation of cytotoxicity and differentiation-inducing potential of arabinofuranosylcytosine in myeloid leukemia cells by hematopoietic cytokines.
    Brach MA, Mertelsmann RH, Herrmann F.
    Cancer Invest; 1993; 11(2):198-211. PubMed ID: 8462021
    [Abstract] [Full Text] [Related]

  • 2. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.
    Hiddemann W, Kiehl M, Zühlsdorf M, Busemann C, Schleyer E, Wörmann B, Büchner T.
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):31-7. PubMed ID: 1553573
    [Abstract] [Full Text] [Related]

  • 3. Treatment with interleukin-3 plus granulocyte-macrophage colony-stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts.
    Bhalla K, Holladay C, Arlin Z, Grant S, Ibrado AM, Jasiok M.
    Blood; 1991 Nov 15; 78(10):2674-9. PubMed ID: 1824260
    [Abstract] [Full Text] [Related]

  • 4. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
    te Boekhorst PA, Löwenberg B, Sonneveld P.
    Leukemia; 1994 Sep 15; 8(9):1480-6. PubMed ID: 7522289
    [Abstract] [Full Text] [Related]

  • 5. Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia.
    Cannistra SA, Groshek P, Griffin JD.
    Leukemia; 1989 May 15; 3(5):328-34. PubMed ID: 2654494
    [Abstract] [Full Text] [Related]

  • 6. Combination of granulocyte colony-stimulating factor and low-dose cytosine arabinoside further enhances myeloid differentiation in leukemia cells in vitro.
    Katagiri T, Miyazawa K, Nishimaki J, Yaguchi M, Kawanishi Y, Ohyashiki K.
    Leuk Lymphoma; 2000 Sep 15; 39(1-2):173-84. PubMed ID: 10975397
    [Abstract] [Full Text] [Related]

  • 7. CSFs in combination with cytosine arabinoside, an inhibitor of DNA synthesis: potential strategies for the treatment of myeloid disorders.
    Brach M, Stone R, Kufe D.
    Biotechnol Ther; 1991 Sep 15; 2(3-4):269-83. PubMed ID: 1845130
    [Abstract] [Full Text] [Related]

  • 8. Colony-stimulating factors (rhG-CSF, rhGM-CSF, rhIL-3, and BCGF) recruit myeloblastic and lymphoblastic leukemic cells and enhance the cytotoxic effects of cytosine-arabinoside.
    Andreeff M, Tafuri A, Hegewisch-Becker S.
    Haematol Blood Transfus; 1990 Sep 15; 33():747-62. PubMed ID: 2323674
    [Abstract] [Full Text] [Related]

  • 9. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
    Tafuri A, De Felice L, Mascolo MG, Valentini T, Petrucci MT, Petti MC.
    Stem Cells; 1993 Jul 15; 11 Suppl 2():88-92. PubMed ID: 7691332
    [Abstract] [Full Text] [Related]

  • 10. Effect of hemopoietic growth factors G-CSF and pIXY 321 on the activity of high dose Ara-C in human myeloid leukemia cells.
    Bhalla K, Tourkina E, Huang Y, Tang C, Mahoney ME, Ibrado AM.
    Leuk Lymphoma; 1993 Jul 15; 10 Suppl():123-31. PubMed ID: 7683227
    [Abstract] [Full Text] [Related]

  • 11. Recombinant GM-CSF modulates the metabolism of cytosine arabinoside in leukemic cells in bone marrow.
    Tanaka M.
    Leuk Res; 1993 Jul 15; 17(7):585-92. PubMed ID: 8326741
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of the cytotoxicity of cytosine arabinoside by interleukin-3.
    Tanaka M.
    Jpn J Cancer Res; 1992 Feb 15; 83(2):194-9. PubMed ID: 1556000
    [Abstract] [Full Text] [Related]

  • 13. Regulation of the genes for interleukin-6 and granulocyte-macrophage colony stimulating factor by different inducers of differentiation in myeloid leukemic cells.
    Shabo Y, Lotem J, Sachs L.
    Leukemia; 1989 Dec 15; 3(12):859-65. PubMed ID: 2685477
    [Abstract] [Full Text] [Related]

  • 14. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
    Budel LM, Delwel R, van Buitenen C, Hoogerbrugge H, Löwenberg B.
    Leukemia; 1993 Mar 15; 7(3):426-34. PubMed ID: 7680401
    [Abstract] [Full Text] [Related]

  • 15. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
    te Boekhorst PA, Löwenberg B, Vlastuin M, Sonneveld P.
    Leukemia; 1993 Aug 15; 7(8):1191-8. PubMed ID: 7688839
    [Abstract] [Full Text] [Related]

  • 16. In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients: factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicity.
    Van der Lely N, De Witte T, Wessels J, Raymakers R, Muus P, Preijers F.
    Ann Hematol; 1994 May 15; 68(5):225-32. PubMed ID: 7517190
    [Abstract] [Full Text] [Related]

  • 17. Enhanced suppression of human myeloid leukemic cell lines by combinations of IL-6, LIF, GM-CSF and G-CSF.
    Maekawa T, Metcalf D, Gearing DP.
    Int J Cancer; 1990 Feb 15; 45(2):353-8. PubMed ID: 1689277
    [Abstract] [Full Text] [Related]

  • 18. Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells.
    Van Der Lely N, De Witte T, Muus P, Raymakers R, Preijers F, Haanen C.
    Exp Hematol; 1991 May 15; 19(4):267-72. PubMed ID: 2055291
    [Abstract] [Full Text] [Related]

  • 19. Heterogeneous effects of G-CSF and GM-CSF on cell growth and ara-C cytotoxicity in childhood leukemias which express myeloid markers.
    Higashigawa M, Kuwabara H, Cao DC, Hori H, Ohkubo T, Kawasaki H, Ido M, Komada Y, Sakurai M.
    Leuk Lymphoma; 1996 Jul 15; 22(3-4):279-85. PubMed ID: 8819077
    [Abstract] [Full Text] [Related]

  • 20. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J, Jarvis WD.
    Cell Growth Differ; 1996 May 15; 7(5):603-13. PubMed ID: 8732670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.